{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:25:39Z","timestamp":1793042739360,"version":"4.5.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"DOI":"10.1038\/s41574-026-01291-4","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:45:47Z","timestamp":1787669147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-6482","authenticated-orcid":false,"given":"Sunita M. C.","family":"De Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4311-5855","authenticated-orcid":false,"given":"Cynthia L.","family":"Andoniadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-2975","authenticated-orcid":false,"given":"Adrian F.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-5725","authenticated-orcid":false,"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-8598","authenticated-orcid":false,"given":"Frederique","family":"Ruf-Zamojski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2244","authenticated-orcid":false,"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-9246","authenticated-orcid":false,"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-2392","authenticated-orcid":false,"given":"Sabrina","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dichtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana G.","family":"Ioachimescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Mallea-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan A.","family":"Niculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-9866","authenticated-orcid":false,"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Zada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-3447","authenticated-orcid":false,"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"1291_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed, S. et al. Clinical biology of the pituitary adenoma. Endocr. Rev. 43, 1003\u20131037 (2022).","journal-title":"Endocr. Rev."},{"key":"1291_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1210\/jcem-71-6-1427","volume":"71","author":"V Herman","year":"1990","unstructured":"Herman, V., Fagin, J., Gonsky, R., Kovacs, K. & Melmed, S. Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab. 71, 1427\u20131433 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-023-00883-8","volume":"19","author":"KKY Ho","year":"2023","unstructured":"Ho, K. K. Y. et al. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification. Nat. Rev. Endocrinol. 19, 671\u2013678 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas, J. et al. How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers 12, 514 (2020).","journal-title":"Cancers"},{"key":"1291_CR5","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-24-0272","volume":"32","author":"SMC De Sousa","year":"2025","unstructured":"De Sousa, S. M. C. From bench to bedside in the sella: translational developments in pituitary tumour genetics. Endocr. Relat. Cancer 32, e240272 (2025).","journal-title":"Endocr. Relat. Cancer"},{"key":"1291_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/cen.14827","volume":"97","author":"F Guaraldi","year":"2022","unstructured":"Guaraldi, F. et al. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients. Clin. Endocrinol. 97, 763\u2013772 (2022).","journal-title":"Clin. Endocrinol."},{"key":"1291_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-16-0944","volume":"176","author":"SMC De Sousa","year":"2017","unstructured":"De Sousa, S. M. C. et al. Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours. Eur. J. Endocrinol. 176, 635\u2013644 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR8","doi-asserted-by":"publisher","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","volume":"105","author":"P Marques","year":"2020","unstructured":"Marques, P. et al. Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors. J. Clin. Endocrinol. Metab. 105, e2247\u2013e2260 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41574-018-0114-1","volume":"14","author":"A Beckers","year":"2018","unstructured":"Beckers, A., Petrossians, P., Hanson, J. & Daly, A. F. The causes and consequences of pituitary gigantism. Nat. Rev. Endocrinol. 14, 705\u2013720 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR10","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1210\/jc.2009-2556","volume":"95","author":"AF Daly","year":"2010","unstructured":"Daly, A. F. et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J. Clin. Endocrinol. Metab. 95, E373\u2013E383 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR11","doi-asserted-by":"publisher","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","volume":"100","author":"LC Hernandez-Ramirez","year":"2015","unstructured":"Hernandez-Ramirez, L. C. et al. Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers. J. Clin. Endocrinol. Metab. 100, E1242\u2013E1254 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1530\/EC-19-0027","volume":"8","author":"AF Daly","year":"2019","unstructured":"Daly, A. F. et al. AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. Endocr. Connect. 8, 338\u2013348 (2019).","journal-title":"Endocr. Connect."},{"key":"1291_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1210\/er.2012-1013","volume":"34","author":"A Beckers","year":"2013","unstructured":"Beckers, A., Aaltonen, L. A., Daly, A. F. & Karhu, A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr. Rev. 34, 239\u2013277 (2013).","journal-title":"Endocr. Rev."},{"key":"1291_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S2213-8587(25)00119-6","volume":"13","author":"ML Brandi","year":"2025","unstructured":"Brandi, M. L. et al. Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice. Lancet Diabetes Endocrinol. 13, 699\u2013721 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1291_CR15","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"Pellegata, N. S. et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl Acad. Sci. USA 103, 15558\u201315563 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1291_CR16","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/jc.2008-2333","volume":"94","author":"J Bertherat","year":"2009","unstructured":"Bertherat, J. et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2019-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085\u20132091 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/79238","volume":"26","author":"LS Kirschner","year":"2000","unstructured":"Kirschner, L. S. et al. Mutations of the gene encoding the protein kinase A type I-\u03b1 regulatory subunit in patients with the Carney complex. Nat. Genet. 26, 89\u201392 (2000).","journal-title":"Nat. Genet."},{"key":"1291_CR18","doi-asserted-by":"publisher","first-page":"L37","DOI":"10.1530\/ERC-18-0065","volume":"25","author":"AF Daly","year":"2018","unstructured":"Daly, A. F. et al. Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocr. Relat. Cancer 25, L37\u2013L42 (2018).","journal-title":"Endocr. Relat. Cancer"},{"key":"1291_CR19","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/ERC-22-0157","volume":"29","author":"PB Loughrey","year":"2022","unstructured":"Loughrey, P. B. et al. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours. Endocr. Relat. Cancer 29, R157\u2013R172 (2022).","journal-title":"Endocr. Relat. Cancer"},{"key":"1291_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/a-0661-0341","volume":"51","author":"P Xekouki","year":"2019","unstructured":"Xekouki, P., Brennand, A., Whitelaw, B., Pacak, K. & Stratakis, C. A. The 3PAs: an update on the association of pheochromocytomas, paragangliomas, and pituitary tumors. Horm. Metab. Res. 51, 419\u2013436 (2019).","journal-title":"Horm. Metab. Res."},{"key":"1291_CR21","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin, G. et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N. Engl. J. Med. 371, 2363\u20132374 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1291_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/340692a0","volume":"340","author":"CA Landis","year":"1989","unstructured":"Landis, C. A. et al. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340, 692\u2013696 (1989).","journal-title":"Nature"},{"key":"1291_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke, M. et al. Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat. Genet. 47, 31\u201338 (2015).","journal-title":"Nat. Genet."},{"key":"1291_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma, Z. Y. et al. Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res. 25, 306\u2013317 (2015).","journal-title":"Cell Res."},{"key":"1291_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/ejendo\/lvad114","volume":"189","author":"J Simon","year":"2023","unstructured":"Simon, J. et al. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours. Eur. J. Endocrinol. 189, 372\u2013378 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41574-023-00948-8","volume":"20","author":"M Korbonits","year":"2024","unstructured":"Korbonits, M. et al. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: part 1, general recommendations. Nat. Rev. Endocrinol. 20, 278\u2013289 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41574-023-00949-7","volume":"20","author":"M Korbonits","year":"2024","unstructured":"Korbonits, M. et al. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: part 2, specific diseases. Nat. Rev. Endocrinol. 20, 290\u2013309 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR28","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1093\/ejendo\/lvaf100","volume":"192","author":"G Raverot","year":"2025","unstructured":"Raverot, G. et al. Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas. Eur. J. Endocrinol. 192, R45\u2013R78 (2025).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn, S. et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement. Nat. Rev. Endocrinol. 19, 722\u2013740 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu, M. et al. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 9, 847\u2013875 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1291_CR31","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt, G. H. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924\u2013926 (2008).","journal-title":"BMJ"},{"key":"1291_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41574-025-01134-8","volume":"21","author":"M Fleseriu","year":"2025","unstructured":"Fleseriu, M. et al. Pituitary incidentaloma: a Pituitary Society International Consensus guideline statement. Nat. Rev. Endocrinol. 21, 638\u2013655 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR33","doi-asserted-by":"publisher","first-page":"R235","DOI":"10.1530\/EJE-19-0602","volume":"181","author":"S Vandeva","year":"2019","unstructured":"Vandeva, S., Daly, A. F., Petrossians, P., Zacharieva, S. & Beckers, A. Somatic and germline mutations in the pathogenesis of pituitary adenomas. Eur. J. Endocrinol. 181, R235\u2013R254 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11102-025-01616-y","volume":"29","author":"C Piazzola","year":"2025","unstructured":"Piazzola, C. et al. From misclassified AIP variant to Carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition. Pituitary 29, 15 (2025).","journal-title":"Pituitary"},{"key":"1291_CR35","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1210\/jc.2005-2671","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly, A. F. et al. Clinical characterization of familial isolated pituitary adenomas. J. Clin. Endocrinol. Metab. 91, 3316\u20133323 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR36","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1126\/science.1126100","volume":"312","author":"O Vierimaa","year":"2006","unstructured":"Vierimaa, O. et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312, 1228\u20131230 (2006).","journal-title":"Science"},{"key":"1291_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tem.2006.09.004","volume":"17","author":"K Balogh","year":"2006","unstructured":"Balogh, K., Racz, K., Patocs, A. & Hunyady, L. Menin and its interacting proteins: elucidation of menin function. Trends Endocrinol. Metab. 17, 357\u2013364 (2006).","journal-title":"Trends Endocrinol. Metab."},{"key":"1291_CR38","doi-asserted-by":"publisher","first-page":"e1482","DOI":"10.1210\/clinem\/dgae055","volume":"109","author":"B Chevalier","year":"2024","unstructured":"Chevalier, B. et al. Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population and literature review. J. Clin. Endocrinol. Metab. 109, e1482\u2013e1493 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR39","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0411","volume":"12","author":"H Singeisen","year":"2023","unstructured":"Singeisen, H. et al. Multiple endocrine neoplasia type 4: a new member of the MEN family. Endocr. Connect. 12, e220411 (2023).","journal-title":"Endocr. Connect."},{"key":"1291_CR40","doi-asserted-by":"publisher","first-page":"dgaa002","DOI":"10.1210\/clinem\/dgaa002","volume":"105","author":"S Espiard","year":"2020","unstructured":"Espiard, S. et al. Frequency and incidence of Carney complex manifestations: a prospective multicenter study with a three-year follow-up. J. Clin. Endocrinol. Metab. 105, dgaa002 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR41","doi-asserted-by":"publisher","first-page":"e694","DOI":"10.1210\/clinem\/dgae253","volume":"110","author":"C Tatsi","year":"2025","unstructured":"Tatsi, C., Pitsava, G., Faucz, F. R., Keil, M. & Stratakis, C. A. The spectrum of GH excess in Carney complex and genotype-phenotype correlations. J. Clin. Endocrinol. Metab. 110, e694\u2013e702 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR42","doi-asserted-by":"publisher","first-page":"189141","DOI":"10.1016\/j.bbcan.2024.189141","volume":"1879","author":"A Cascon","year":"2024","unstructured":"Cascon, A. & Robledo, M. Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma. Biochim. Biophys. Acta Rev. Cancer 1879, 189141 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"1291_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1530\/EJE-20-0054","volume":"183","author":"G Mougel","year":"2020","unstructured":"Mougel, G. et al. Germinal defects of SDHx genes in patients with isolated pituitary adenoma. Eur. J. Endocrinol. 183, 369\u2013379 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR44","doi-asserted-by":"publisher","first-page":"e3635","DOI":"10.1210\/clinem\/dgaf149","volume":"110","author":"A Fernandez-Pombo","year":"2025","unstructured":"Fernandez-Pombo, A. et al. New insights into the clinical characterization of SDHAF2-related familial paraganglioma syndrome. J. Clin. Endocrinol. Metab. 110, e3635\u2013e3647 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR45","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","volume":"106","author":"AJ Seabrook","year":"2021","unstructured":"Seabrook, A. J. et al. Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5? J. Clin. Endocrinol. Metab. 106, 1163\u20131182 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01378-5","volume":"16","author":"AF Daly","year":"2024","unstructured":"Daly, A. F. et al. Chromatin conformation capture in the clinic: 4C-seq\/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus. Genome Med. 16, 112 (2024).","journal-title":"Genome Med."},{"key":"1291_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11102-025-01559-4","volume":"28","author":"C Hilditch","year":"2025","unstructured":"Hilditch, C., Curtis, S., Cotton, S., LeBlanc, S. & De Sousa, S. Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism. Pituitary 28, 85 (2025).","journal-title":"Pituitary"},{"key":"1291_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41525-025-00548-7","volume":"11","author":"G Trivellin","year":"2026","unstructured":"Trivellin, G. et al. Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE. NPJ Genom. Med. 11, 12 (2026).","journal-title":"NPJ Genom. Med."},{"key":"1291_CR49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1210\/endrev\/bnae014","volume":"45","author":"AF Daly","year":"2024","unstructured":"Daly, A. F. & Beckers, A. The genetic pathophysiology and clinical management of the TADopathy, X-linked acrogigantism. Endocr. Rev. 45, 737\u2013754 (2024).","journal-title":"Endocr. Rev."},{"key":"1291_CR50","doi-asserted-by":"publisher","first-page":"T77","DOI":"10.1530\/ERC-20-0015","volume":"27","author":"V Vasilev","year":"2020","unstructured":"Vasilev, V. et al. Hereditary endocrine tumours: current state-of-the-art and research opportunities: the roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA). Endocr. Relat. Cancer 27, T77\u2013T86 (2020).","journal-title":"Endocr. Relat. Cancer"},{"key":"1291_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-12","volume":"3","author":"CE Dumitrescu","year":"2008","unstructured":"Dumitrescu, C. E. & Collins, M. T. McCune-Albright syndrome. Orphanet J. Rare Dis. 3, 12 (2008).","journal-title":"Orphanet J. Rare Dis."},{"key":"1291_CR52","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1210\/jc.2001-012022","volume":"87","author":"SO Akintoye","year":"2002","unstructured":"Akintoye, S. O. et al. Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J. Clin. Endocrinol. Metab. 87, 5104\u20135112 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR53","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein, L. S. et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325, 1688\u20131695 (1991).","journal-title":"N. Engl. J. Med."},{"key":"1291_CR54","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1210\/jc.2003-031225","volume":"89","author":"S Lumbroso","year":"2004","unstructured":"Lumbroso, S., Paris, F., Sultan, C. & European Collaborative Study. Activating Gs\u03b1 mutations: analysis of 113 patients with signs of McCune-Albright syndrome \u2014 a European Collaborative Study. J. Clin. Endocrinol. Metab. 89, 2107\u20132113 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR55","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1507\/endocrj.EJ17-0036","volume":"64","author":"S Uraki","year":"2017","unstructured":"Uraki, S. et al. Atypical pituitary adenoma with MEN1 somatic mutation associated with abnormalities of DNA mismatch repair genes; MLH1 germline mutation and MSH6 somatic mutation. Endocr. J. 64, 895\u2013906 (2017).","journal-title":"Endocr. J."},{"key":"1291_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cancergen.2021.03.008","volume":"256-257","author":"PB Loughrey","year":"2021","unstructured":"Loughrey, P. B. et al. Invasive ACTH-producing pituitary gland neoplasm secondary to MSH2 mutation. Cancer Genet. 256-257, 36\u201339 (2021).","journal-title":"Cancer Genet."},{"key":"1291_CR57","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/02688697.2021.1967881","volume":"38","author":"J Teuber","year":"2024","unstructured":"Teuber, J. et al. Aggressive pituitary adenoma in the context of Lynch syndrome: a case report and literature review on this rare coincidence. Br. J. Neurosurg. 38, 775\u2013780 (2024).","journal-title":"Br. J. Neurosurg."},{"key":"1291_CR58","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1210\/jc.2017-01401","volume":"102","author":"D Bengtsson","year":"2017","unstructured":"Bengtsson, D. et al. Corticotroph pituitary carcinoma in a patient with Lynch syndrome (LS) and pituitary tumors in a nationwide LS cohort. J. Clin. Endocrinol. Metab. 102, 3928\u20133932 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR59","volume":"18","author":"V Bares","year":"2026","unstructured":"Bares, V. & Netuka, D. Recurrent pituitary adenoma causing cushing\u2019s disease in a patient with lynch syndrome. Cureus 18, e102414 (2026).","journal-title":"Cureus"},{"key":"1291_CR60","first-page":"2720","volume":"109","author":"SMC De Sousa","year":"2024","unstructured":"De Sousa, S. M. C. et al. Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas. J. Clin. Endocrinol. Metab. 109, 2720\u20132728 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR61","volume":"40","author":"LM Gaspar","year":"2025","unstructured":"Gaspar, L. M. et al. Germline genetic variants in young-onset sporadic pituitary macroadenomas: a multigene panel analysis. J. Clin. Transl. Endocrinol. 40, 100389 (2025).","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"1291_CR62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-025-05140-8","volume":"175","author":"A Orsmond","year":"2025","unstructured":"Orsmond, A., De Sousa, S. M. C. & McCormack, A. The landscape of germline variants in breast and colorectal cancer susceptibility genes in patients with pituitary tumours. J. Neurooncol. 175, 379\u2013388 (2025).","journal-title":"J. Neurooncol."},{"key":"1291_CR63","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae085","volume":"8","author":"AS Alzahrani","year":"2024","unstructured":"Alzahrani, A. S. et al. Germline variants in sporadic pituitary adenomas. J. Endocr. Soc. 8, bvae085 (2024).","journal-title":"J. Endocr. Soc."},{"key":"1291_CR64","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMc1309730","volume":"370","author":"A Forlino","year":"2014","unstructured":"Forlino, A. et al. PRKACB and Carney complex. N. Engl. J. Med. 370, 1065\u20131067 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1291_CR65","doi-asserted-by":"publisher","first-page":"e1926","DOI":"10.1210\/clinem\/dgag195","volume":"111","author":"E Mignone","year":"2026","unstructured":"Mignone, E., Sorvina, A., Torpy, D. J., Scott, H. S. & De Sousa, S. M. C. The germline landscape of pituitary adenomas: established and emerging predisposition genes. J. Clin. Endocrinol. Metab. 111, e1926\u2013e1936 (2026).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/ejendo\/lvag074","volume":"194","author":"I Martinez de Lapiscina","year":"2026","unstructured":"Martinez de Lapiscina, I. et al. Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas. Eur. J. Endocrinol. 194, 603\u2013614 (2026).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR67","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3390\/jcm11082168","volume":"11","author":"F Hannah-Shmouni","year":"2022","unstructured":"Hannah-Shmouni, F. et al. Neurofibromatosis type 1 has a wide spectrum of growth hormone excess. J. Clin. Med. 11, 2168 (2022).","journal-title":"J. Clin. Med."},{"key":"1291_CR68","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-22-0291","volume":"257","author":"SMC De Sousa","year":"2023","unstructured":"De Sousa, S. M. C., Lenders, N. F., Lamb, L. S., Inder, W. J. & McCormack, A. Pituitary tumours: molecular and genetic aspects. J. Endocrinol. 257, e220291 (2023).","journal-title":"J. Endocrinol."},{"key":"1291_CR69","doi-asserted-by":"crossref","unstructured":"Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J. Clin. Oncol. 14, 1730\u20131736 (1996).","DOI":"10.1200\/JCO.1996.14.5.1730"},{"key":"1291_CR70","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jmedgenet-2017-104957","volume":"55","author":"F Caimari","year":"2018","unstructured":"Caimari, F. et al. Risk category system to identify pituitary adenoma patients with AIP mutations. J. Med. Genet. 55, 254\u2013260 (2018).","journal-title":"J. Med. Genet."},{"key":"1291_CR71","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/EJE-11-0304","volume":"165","author":"MA Tichomirowa","year":"2011","unstructured":"Tichomirowa, M. A. et al. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur. J. Endocrinol. 165, 509\u2013515 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR72","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.176993","volume":"10","author":"CC Worthy","year":"2025","unstructured":"Worthy, C. C. et al. Genotype-phenotype correlation in multiple endocrine neoplasia type 1. JCI Insight 10, e176993 (2025).","journal-title":"JCI Insight"},{"key":"1291_CR73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","volume":"87","author":"B Verges","year":"2002","unstructured":"Verges, B. et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J. Clin. Endocrinol. Metab. 87, 457\u2013465 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR74","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","volume":"100","author":"P Goudet","year":"2015","unstructured":"Goudet, P. et al. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019etude des Tumeurs Endocrines. J. Clin. Endocrinol. Metab. 100, 1568\u20131577 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR75","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","volume":"42","author":"ML Brandi","year":"2021","unstructured":"Brandi, M. L. et al. Multiple endocrine neoplasia type 1: latest insights. Endocr. Rev. 42, 133\u2013170 (2021).","journal-title":"Endocr. Rev."},{"key":"1291_CR76","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1210\/jc.2014-3670","volume":"100","author":"S Salenave","year":"2015","unstructured":"Salenave, S. et al. Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. J. Clin. Endocrinol. Metab. 100, 1177\u20131186 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR77","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S2213-8587(25)00118-4","volume":"13","author":"KA English","year":"2025","unstructured":"English, K. A. et al. Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis. Lancet Diabetes Endocrinol. 13, 685\u2013698 (2025).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1291_CR78","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","volume":"105","author":"F Chasseloup","year":"2020","unstructured":"Chasseloup, F. et al. Germline CDKN1B loss-of-function variants cause pediatric Cushing\u2019s disease with or without an MEN4 phenotype. J. Clin. Endocrinol. Metab. 105, 1983\u20132005 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR79","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1210\/jc.2017-01045","volume":"102","author":"M Stelmachowska-Banas","year":"2017","unstructured":"Stelmachowska-Banas, M., Zgliczynski, W., Tutka, P., Carney, J. A. & Korbonits, M. Fatal carney complex in siblings due to de novo large gene deletion. J. Clin. Endocrinol. Metab. 102, 3924\u20133927 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpeds.2018.09.070","volume":"205","author":"P Romanet","year":"2019","unstructured":"Romanet, P. et al. Using digital droplet polymerase chain reaction to detect the mosaic GNAS mutations in whole blood DNA or circulating cell-free DNA in fibrous dysplasia and McCune-Albright syndrome. J. Pediatr. 205, 281\u2013285.e4 (2019).","journal-title":"J. Pediatr."},{"key":"1291_CR81","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jc.2013-3826","volume":"99","author":"S Salenave","year":"2014","unstructured":"Salenave, S., Boyce, A. M., Collins, M. T. & Chanson, P. Acromegaly and McCune-Albright syndrome. J. Clin. Endocrinol. Metab. 99, 1955\u20131969 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR82","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11154-016-9400-1","volume":"17","author":"CA Stratakis","year":"2016","unstructured":"Stratakis, C. A. Carney complex: a familial lentiginosis predisposing to a variety of tumors. Rev. Endocr. Metab. Disord. 17, 367\u2013371 (2016).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"1291_CR83","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12020-021-02636-x","volume":"71","author":"H Butz","year":"2021","unstructured":"Butz, H., Blair, J. & Patocs, A. Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes. Endocrine 71, 641\u2013652 (2021).","journal-title":"Endocrine"},{"key":"1291_CR84","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg3493","volume":"14","author":"SH Katsanis","year":"2013","unstructured":"Katsanis, S. H. & Katsanis, N. Molecular genetic testing and the future of clinical genomics. Nat. Rev. Genet. 14, 415\u2013426 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"1291_CR85","first-page":"9.15.11","volume":"81","author":"W Burke","year":"2014","unstructured":"Burke, W. Genetic tests: clinical validity and clinical utility. Curr. Protoc. Hum. Genet. 81, 9.15.11\u201319.15.18 (2014).","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"1291_CR86","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/cen.14706","volume":"97","author":"EC Coopmans","year":"2022","unstructured":"Coopmans, E. C. & Korbonits, M. Molecular genetic testing in the management of pituitary disease. Clin. Endocrinol. 97, 424\u2013435 (2022).","journal-title":"Clin. Endocrinol."},{"key":"1291_CR87","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/cen.14053","volume":"91","author":"PJ Newey","year":"2019","unstructured":"Newey, P. J. Clinical genetic testing in endocrinology: current concepts and contemporary challenges. Clin. Endocrinol. 91, 587\u2013607 (2019).","journal-title":"Clin. Endocrinol."},{"key":"1291_CR88","unstructured":"Korbonits, M. & Hernandez-Ramirez, L. C. in GeneReviews (eds Adam, M. P. et al.) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK97965\/ (2025)."},{"key":"1291_CR89","unstructured":"Cancer Genetics Risk Assessment and Counseling (PDQ): Health Professional Version. National Cancer Institute PDQ Cancer Information Summaries https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK65817\/ (2025)."},{"key":"1291_CR90","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/endrev\/bnac024","volume":"44","author":"MD Ilie","year":"2023","unstructured":"Ilie, M. D., Vasiljevic, A., Bertolino, P. & Raverot, G. Biological and therapeutic implications of the tumor microenvironment in pituitary adenomas. Endocr. Rev. 44, 297\u2013311 (2023).","journal-title":"Endocr. Rev."},{"key":"1291_CR91","doi-asserted-by":"publisher","DOI":"10.1200\/GO-24-00337","volume":"11","author":"ABA Souza","year":"2025","unstructured":"Souza, A. B. A. et al. Germline genetic testing in breast cancer: utilization and disparities in a middle-income country. JCO Glob. Oncol. 11, e2400337 (2025).","journal-title":"JCO Glob. Oncol."},{"key":"1291_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jlb\/lsz007","volume":"6","author":"EW Clayton","year":"2019","unstructured":"Clayton, E. W., Evans, B. J., Hazel, J. W. & Rothstein, M. A. The law of genetic privacy: applications, implications, and limitations. J. Law Biosci. 6, 1\u201336 (2019).","journal-title":"J. Law Biosci."},{"key":"1291_CR93","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1542\/peds.2012-3680","volume":"131","author":"Committee on Bioethics","year":"2013","unstructured":"Committee on Bioethics et al. Ethical and policy issues in genetic testing and screening of children. Pediatrics 131, 620\u2013622 (2013).","journal-title":"Pediatrics"},{"key":"1291_CR94","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1001\/jama.2017.0432","volume":"317","author":"JP Evans","year":"2017","unstructured":"Evans, J. P., Powell, B. C. & Berg, J. S. Finding the rare pathogenic variants in a human genome. JAMA 317, 1904\u20131905 (2017).","journal-title":"JAMA"},{"key":"1291_CR95","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/jpm10020030","volume":"10","author":"GL Wiesner","year":"2020","unstructured":"Wiesner, G. L. et al. Returning results in the genomic era: initial experiences of the eMERGE network. J. Pers. Med. 10, 30 (2020).","journal-title":"J. Pers. Med."},{"key":"1291_CR96","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/jhg.2015.151","volume":"61","author":"A Wauters","year":"2016","unstructured":"Wauters, A. & Van Hoyweghen, I. Global trends on fears and concerns of genetic discrimination: a systematic literature review. J. Hum. Genet. 61, 275\u2013282 (2016).","journal-title":"J. Hum. Genet."},{"key":"1291_CR97","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.med.54.101601.152131","volume":"54","author":"P Sankar","year":"2003","unstructured":"Sankar, P. Genetic privacy. Annu. Rev. Med. 54, 393\u2013407 (2003).","journal-title":"Annu. Rev. Med."},{"key":"1291_CR98","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ejhg.2010.104","volume":"18","author":"S Berwouts","year":"2010","unstructured":"Berwouts, S., Morris, M. A. & Dequeker, E. Approaches to quality management and accreditation in a genetic testing laboratory. Eur. J. Hum. Genet. 18, S1\u2013S19 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"1291_CR99","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"1291_CR100","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/cen.14596","volume":"97","author":"L Izatt","year":"2022","unstructured":"Izatt, L., Owens, M. M., Pierce, H., Wilcox, S. & Park, S. M. A practical guide to genetic testing in endocrinology. Clin. Endocrinol. 97, 388\u2013399 (2022).","journal-title":"Clin. Endocrinol."},{"key":"1291_CR101","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1210\/clinem\/dgae300","volume":"109","author":"A Patocs","year":"2024","unstructured":"Patocs, A. et al. Cost-effectiveness of genetic testing of endocrine tumor patients using a comprehensive hereditary cancer gene panel. J. Clin. Endocrinol. Metab. 109, 3220\u20133233 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR102","doi-asserted-by":"publisher","first-page":"T65","DOI":"10.1530\/ERC-19-0454","volume":"27","author":"P Brock","year":"2020","unstructured":"Brock, P. et al. Hereditary endocrine tumours: current state-of-the-art and research opportunities: challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes. Endocr. Relat. Cancer 27, T65\u2013T75 (2020).","journal-title":"Endocr. Relat. Cancer"},{"key":"1291_CR103","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/humu.23746","volume":"40","author":"P Romanet","year":"2019","unstructured":"Romanet, P. et al. Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variants. Hum. Mutat. 40, 661\u2013674 (2019).","journal-title":"Hum. Mutat."},{"key":"1291_CR104","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum, M. J. et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44, D862\u2013D868 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1291_CR105","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm, H. L. et al. ClinGen-the clinical genome resource. N. Engl. J. Med. 372, 2235\u20132242 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1291_CR106","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00439-022-02457-6","volume":"141","author":"P Katsonis","year":"2022","unstructured":"Katsonis, P., Wilhelm, K., Williams, A. & Lichtarge, O. Genome interpretation using in silico predictors of variant impact. Hum. Genet. 141, 1549\u20131577 (2022).","journal-title":"Hum. Genet."},{"key":"1291_CR107","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41431-024-01554-6","volume":"32","author":"L Basel-Salmon","year":"2024","unstructured":"Basel-Salmon, L. Phenotypic compatibility and specificity in genomic variant classification. Eur. J. Hum. Genet. 32, 471\u2013473 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"1291_CR108","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","volume":"111","author":"LG Biesecker","year":"2024","unstructured":"Biesecker, L. G. et al. ClinGen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification. Am. J. Hum. Genet. 111, 24\u201338 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"1291_CR109","doi-asserted-by":"publisher","first-page":"101892","DOI":"10.1016\/j.beem.2024.101892","volume":"38","author":"C Ramirez-Renteria","year":"2024","unstructured":"Ramirez-Renteria, C. & Hernandez-Ramirez, L. C. Genetic diagnosis in acromegaly and gigantism: from research to clinical practice. Best Pract. Res. Clin. Endocrinol. Metab. 38, 101892 (2024).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"1291_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-01059-x","volume":"14","author":"AK Singh","year":"2021","unstructured":"Singh, A. K. et al. Detecting copy number variation in next generation sequencing data from diagnostic gene panels. BMC Med. Genomics 14, 214 (2021).","journal-title":"BMC Med. Genomics"},{"key":"1291_CR111","doi-asserted-by":"publisher","first-page":"102920","DOI":"10.1016\/j.arcmed.2023.102920","volume":"54","author":"G Akkus","year":"2023","unstructured":"Akkus, G. & Korbonits, M. Genetic testing in hereditary pituitary tumors. Arch. Med. Res. 54, 102920 (2023).","journal-title":"Arch. Med. Res."},{"key":"1291_CR112","doi-asserted-by":"publisher","first-page":"E1248","DOI":"10.1210\/jc.2013-1319","volume":"98","author":"E Rattenberry","year":"2013","unstructured":"Rattenberry, E. et al. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. J. Clin. Endocrinol. Metab. 98, E1248\u2013E1256 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR113","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-0476","volume":"92","author":"E Tham","year":"2007","unstructured":"Tham, E. et al. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J. Clin. Endocrinol. Metab. 92, 3389\u20133395 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR114","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1210\/clinem\/dgag151","volume":"111","author":"SMC De Sousa","year":"2026","unstructured":"De Sousa, S. M. C. & Daly, A. F. Genetics of familial acromegaly and pituitary gigantism. J. Clin. Endocrinol. Metab. 111, S13\u2013S26 (2026).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR115","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0093","volume":"11","author":"A Lagarde","year":"2022","unstructured":"Lagarde, A. et al. Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms. Endocr. Connect. 11, e220093 (2022).","journal-title":"Endocr. Connect."},{"key":"1291_CR116","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jbmr.4766","volume":"38","author":"KL Roszko","year":"2023","unstructured":"Roszko, K. L. et al. Identification of GNAS variants in circulating cell-free DNA from patients with fibrous dysplasia\/McCune Albright syndrome. J. Bone Min. Res. 38, 443\u2013450 (2023).","journal-title":"J. Bone Min. Res."},{"key":"1291_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060525","volume":"8","author":"S Narumi","year":"2013","unstructured":"Narumi, S., Matsuo, K., Ishii, T., Tanahashi, Y. & Hasegawa, T. Quantitative and sensitive detection of GNAS mutations causing mccune-albright syndrome with next generation sequencing. PLoS One 8, e60525 (2013).","journal-title":"PLoS One"},{"key":"1291_CR118","unstructured":"Szymczuk, V. et al. in GeneReviews (eds Adam, M. P. et al.) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK274564\/ (2024)."},{"key":"1291_CR119","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/genes15010120","volume":"15","author":"Y Vado","year":"2024","unstructured":"Vado, Y., Manero-Azua, A., Pereda, A. & Perez de Nanclares, G. Choosing the best tissue and technique to detect mosaicism in fibrous dysplasia\/McCune-Albright syndrome (FD\/MAS). Genes 15, 120 (2024).","journal-title":"Genes"},{"key":"1291_CR120","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1093\/ejendo\/lvaf247","volume":"193","author":"O Papalou","year":"2025","unstructured":"Papalou, O. & Korbonits, M. New directions in MEN1 management: navigating the new clinical practice guidelines. Eur. J. Endocrinol. 193, R71\u2013R82 (2025).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR121","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1210\/clinem\/dgaf704","volume":"111","author":"YB Omotosho","year":"2026","unstructured":"Omotosho, Y. B. et al. Radiological surveillance for pituitary adenomas in multiple endocrine neoplasia type 1: a longitudinal cohort study. J. Clin. Endocrinol. Metab. 111, 1575\u20131583 (2026).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR122","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/s41431-020-00725-5","volume":"28","author":"S Srinivasan","year":"2020","unstructured":"Srinivasan, S., Won, N. Y., Dotson, W. D., Wright, S. T. & Roberts, M. C. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur. J. Hum. Genet. 28, 1631\u20131644 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"1291_CR123","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-21-0462","volume":"185","author":"A Luger","year":"2021","unstructured":"Luger, A. et al. ESE clinical practice guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. Eur. J. Endocrinol. 185, G1\u2013G33 (2021).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR124","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.semcdb.2015.05.011","volume":"43","author":"AS Hoekstra","year":"2015","unstructured":"Hoekstra, A. S., Devilee, P. & Bayley, J. P. Models of parent-of-origin tumorigenesis in hereditary paraganglioma. Semin. Cell Dev. Biol. 43, 117\u2013124 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1291_CR125","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","volume":"17","author":"A Al-Salameh","year":"2021","unstructured":"Al-Salameh, A., Cadiot, G., Calender, A., Goudet, P. & Chanson, P. Clinical aspects of multiple endocrine neoplasia type 1. Nat. Rev. Endocrinol. 17, 207\u2013224 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR126","first-page":"67","volume":"22","author":"AD Lima","year":"2018","unstructured":"Lima, A. D. et al. Preimplantation genetic diagnosis for a patient with multiple endocrine neoplasia type 1: case report. JBRA Assist. Reprod. 22, 67\u201370 (2018).","journal-title":"JBRA Assist. Reprod."},{"key":"1291_CR127","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/pd.5662","volume":"40","author":"T Hardy","year":"2020","unstructured":"Hardy, T. The role of prenatal diagnosis following preimplantation genetic testing for single-gene conditions: a historical overview of evolving technologies and clinical practice. Prenat. Diagn. 40, 647\u2013651 (2020).","journal-title":"Prenat. Diagn."},{"key":"1291_CR128","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ejendo\/lvaf044","volume":"192","author":"PB Loughrey","year":"2025","unstructured":"Loughrey, P. B. et al. Reassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis. Eur. J. Endocrinol. 192, 385\u2013397 (2025).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR129","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-biodatasci-102423-112456","volume":"7","author":"MW Wright","year":"2024","unstructured":"Wright, M. W. et al. Generating clinical-grade gene-disease validity classifications through the clingen data platforms. Annu. Rev. Biomed. Data Sci. 7, 31\u201350 (2024).","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"1291_CR130","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa071","volume":"4","author":"SMC De Sousa","year":"2020","unstructured":"De Sousa, S. M. C. et al. Aberrant splicing of SDHC in families with unexplained succinate dehydrogenase-deficient paragangliomas. J. Endocr. Soc. 4, bvaa071 (2020).","journal-title":"J. Endocr. Soc."},{"key":"1291_CR131","doi-asserted-by":"publisher","first-page":"101183","DOI":"10.1016\/j.lanepe.2024.101183","volume":"50","author":"PFMG Contributors.","year":"2025","unstructured":"PFMG Contributors.PFMG2025-integrating genomic medicine into the national healthcare system in France. Lancet Reg. Health Eur. 50, 101183 (2025).","journal-title":"Lancet Reg. Health Eur."},{"key":"1291_CR132","doi-asserted-by":"publisher","first-page":"628946","DOI":"10.3389\/fendo.2020.628946","volume":"11","author":"AM McInerney-Leo","year":"2020","unstructured":"McInerney-Leo, A. M. & Duncan, E. L. Massively parallel sequencing for rare genetic disorders: potential and pitfalls. Front. Endocrinol. 11, 628946 (2020).","journal-title":"Front. Endocrinol."},{"key":"1291_CR133","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2213-8587(25)00396-1","volume":"14","author":"Q Zhang","year":"2026","unstructured":"Zhang, Q. et al. Risk of recurrence after successful surgery for Cushing\u2019s disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study. Lancet Diabetes Endocrinol. 14, 327\u2013336 (2026).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1291_CR134","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/EJE-15-1064","volume":"174","author":"CL Ronchi","year":"2016","unstructured":"Ronchi, C. L. et al. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur. J. Endocrinol. 174, 363\u2013372 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR135","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.3390\/cancers14163861","volume":"14","author":"M Yamamoto","year":"2022","unstructured":"Yamamoto, M. & Takahashi, Y. Genetic and epigenetic pathogenesis of acromegaly. Cancers 14, 3861 (2022).","journal-title":"Cancers"},{"key":"1291_CR136","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou, M. et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37, 123\u2013134 (2020).","journal-title":"Cancer Cell"},{"key":"1291_CR137","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1530\/ERC-18-0565","volume":"27","author":"M Puig-Domingo","year":"2020","unstructured":"Puig-Domingo, M. et al. Molecular profiling for acromegaly treatment: a validation study. Endocr. Relat. Cancer 27, 375\u2013389 (2020).","journal-title":"Endocr. Relat. Cancer"},{"key":"1291_CR138","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1093\/ejendo\/lvaf097","volume":"192","author":"LG Perez-Rivas","year":"2025","unstructured":"Perez-Rivas, L. G., von Selzam, V., Sharma, P., Reincke, M. & Theodoropoulou, M. Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases. Eur. J. Endocrinol. 192, S41\u2013S52 (2025).","journal-title":"Eur. J. Endocrinol."},{"key":"1291_CR139","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3593","volume":"362","author":"R Cristescu","year":"2018","unstructured":"Cristescu, R. et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362, eaar3593 (2018).","journal-title":"Science"},{"key":"1291_CR140","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413 (2017).","journal-title":"Science"},{"key":"1291_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105061","volume":"10","author":"A Ronaghy","year":"2025","unstructured":"Ronaghy, A. et al. Clinical outcomes of tumor-agnostic targeting of BRAF, tumor mutation burden-high, and RET. ESMO Open 10, 105061 (2025).","journal-title":"ESMO Open"},{"key":"1291_CR142","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1210\/clinem\/dgaf178","volume":"110","author":"AL Lin","year":"2025","unstructured":"Lin, A. L. et al. Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumors. J. Clin. Endocrinol. Metab. 110, 3066\u20133073 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05275-5","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease. Nat. Commun. 9, 3171 (2018).","journal-title":"Nat. Commun."},{"key":"1291_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16052-8","volume":"11","author":"C Li","year":"2020","unstructured":"Li, C. et al. Somatic SF3B1 hotspot mutation in prolactinomas. Nat. Commun. 11, 2506 (2020).","journal-title":"Nat. Commun."},{"key":"1291_CR145","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40478-022-01437-1","volume":"10","author":"LG Perez-Rivas","year":"2022","unstructured":"Perez-Rivas, L. G. et al. TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome. Acta Neuropathol. Commun. 10, 139 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"1291_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1302667","volume":"15","author":"M Pekul","year":"2024","unstructured":"Pekul, M. et al. Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors. Front. Endocrinol. 15, 1302667 (2024).","journal-title":"Front. Endocrinol."},{"key":"1291_CR147","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.gim.2022.04.006","volume":"24","author":"DT Miller","year":"2022","unstructured":"Miller, D. T. et al. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 24, 1407\u20131414 (2022).","journal-title":"Genet. Med."},{"key":"1291_CR148","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.annonc.2022.12.003","volume":"34","author":"Z Kuzbari","year":"2023","unstructured":"Kuzbari, Z. et al. Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO precision medicine working group recommendations. Ann. Oncol. 34, 215\u2013227 (2023).","journal-title":"Ann. Oncol."},{"key":"1291_CR149","doi-asserted-by":"publisher","DOI":"10.1172\/JCI190264","volume":"135","author":"D Jaber","year":"2025","unstructured":"Jaber, D., Zhang, J. & Godley, L. A. Detecting likely germline variants during tumor-based molecular profiling. J. Clin. Invest. 135, e190264 (2025).","journal-title":"J. Clin. Invest."},{"key":"1291_CR150","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/neuonc\/noab044","volume":"23","author":"MS Mosella","year":"2021","unstructured":"Mosella, M. S. et al. DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features. Neuro-Oncology 23, 1292\u20131303 (2021).","journal-title":"Neuro-Oncology"},{"key":"1291_CR151","first-page":"105","volume":"98","author":"JP Castano","year":"2025","unstructured":"Castano, J. P. et al. EndoCompass Project: research roadmap for pituitary and neuroendocrine tumor endocrinology. Horm. Res. Paediatr. 98, 105\u2013120 (2025).","journal-title":"Horm. Res. Paediatr."},{"key":"1291_CR152","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1210\/jc.2019-00432","volume":"104","author":"P Dutta","year":"2019","unstructured":"Dutta, P. et al. Surgery, octreotide, temozolomide, bevacizumab, radiotherapy, and pegvisomant treatment of an AIP mutation-positive child. J. Clin. Endocrinol. Metab. 104, 3539\u20133544 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR153","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41574-024-01024-5","volume":"20","author":"RT Casey","year":"2024","unstructured":"Casey, R. T. et al. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat. Rev. Endocrinol. 20, 729\u2013748 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR154","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","volume":"86","author":"CA Stratakis","year":"2001","unstructured":"Stratakis, C. A., Kirschner, L. S. & Carney, J. A. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J. Clin. Endocrinol. Metab. 86, 4041\u20134046 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1291_CR155","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","volume":"17","author":"L Amar","year":"2021","unstructured":"Amar, L. et al. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat. Rev. Endocrinol. 17, 435\u2013444 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1291_CR156","unstructured":"eviQ. MEN1 or CDKN1B \u2013 risk management. Cancer Institute NSW https:\/\/www.eviq.org.au\/cancer-genetics\/adult\/risk-management\/192-men1-or-cdkn1b-risk-management# (2022)."},{"key":"1291_CR157","unstructured":"Stratakis, C. A. in GeneReviews (eds Adam M. P. et al.) https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1286\/ (2023)."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01291-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:07:41Z","timestamp":1787670461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01291-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":157,"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1038\/s41574-026-01291-4","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"27 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}